Host: Kirk Campbell, University of Pennsylvania

Guests: Joshua Albright, Kidney Health Advocate & Titilayo Ilori, Boston University

Join our host Dr. Kirk Campbell (University of Pennsylvania) as he speaks with Dr. Titilayo Ilori (Boston University) and patient advocate Joshua Albright about APOL1 screening and early detection.

This episode addresses the low public awareness of APOL1-mediated kidney disease and the challenge of making genetic testing routinely and equitably available. The discussion emphasizes the importance of APOL1 testing for precision medicine and risk stratification. Find out why it’s so important to spread awareness, ensure equity in testing, and foster community engagement to advance knowledge and support those at risk.

This series is provided by KDIGO and supported by Vertex.